Showing results (291-300 of 457) with videos related to
Sort By:
Pageof 46
Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology|June 25, 2010
A pheromone to behave, a pheromone to learn: the rabbit mammary pheromoneGérard Coureaud, Rachel Charra, Frédérique Datiche, et al.Joint Bone Spine|December 5, 2017
Remaining local subclinical joint inflammation is associated with deteriorated metacarpeal head bone microarchitecture in rheumatoid arthritis patients low disease activityShuing Kong, Hervé Locrelle, Adamah Amouzougan, et al.Clinical and Experimental Rheumatology|August 28, 2018
A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritisMartin Soubrier, Céline Lambert, Bernard Combe, et al.Food Chemistry|October 24, 2025
Two complementary analytical approaches to study odorant metabolism in the olfactory epitheliumNicole Kornbausch, Rémy Reynaud, Andrea Buettner, et al.Bulletin Du Cancer|September 11, 2023
Advanced practice nurse management in multiple myeloma treated with oral therapyManon Sapet, Cécile Migala, Elisabeth Daguenet, et al.Annales De Biologie Clinique|December 30, 2015
[Recommendations for the measurement of blood 25-OH vitamin D]Jean-Claude Souberbielle, Georges Deschenes, Denis Fouque, et al.Calcified Tissue International|January 23, 2022
Bone Involvement in Patients with SpondyloarthropathiesWillem Lems, Corinne Miceli-Richard, Judith Haschka, et al.Calcified Tissue International|August 6, 2013
Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosisChristian Roux, Neil Binkley, Steven Boonen, et al.Bone|November 9, 2011
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronatePhilip N Sambrook, Christian Roux, Jean-Pierre Devogelaer, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapyDavid L Kendler, Christian Roux, Claude Laurent Benhamou, et al.Pageof 46